Skip to main content
. 2020 Jun 15;35:1533317520927169. doi: 10.1177/1533317520927169

Figure 2.

Figure 2.

Potential treatment strategy of bone marrow–derived microglia (BMDM) recruitment into the brain. The treatment acts on different stages in the pathogenesis of Alzheimer’s disease (AD). This treatment clears amyloid β (Aβ) ultimately involved stimulating recruitment of BMDM, promoting BMDM clearing Aβ.